These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 6275779

  • 1. Pharmacokinetics of ceftriaxone in humans.
    Patel IH, Chen S, Parsonnet M, Hackman MR, Brooks MA, Konikoff J, Kaplan SA.
    Antimicrob Agents Chemother; 1981 Nov; 20(5):634-41. PubMed ID: 6275779
    [Abstract] [Full Text] [Related]

  • 2. Ceftriaxone pharmacokinetics in patients with various degrees of renal impairment.
    Patel IH, Sugihara JG, Weinfeld RE, Wong EG, Siemsen AW, Berman SJ.
    Antimicrob Agents Chemother; 1984 Apr; 25(4):438-42. PubMed ID: 6329080
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetic characteristics of intravenous ceftriaxone in normal adults.
    Pollock AA, Tee PE, Patel IH, Spicehandler J, Simberkoff MS, Rahal JJ.
    Antimicrob Agents Chemother; 1982 Nov; 22(5):816-23. PubMed ID: 6295268
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of cefaronide, ceftriaxone and cefoperazone in sheep.
    Guerrini VH, Filippich LJ, Cao GR, English PB, Bourne DW.
    J Vet Pharmacol Ther; 1985 Jun; 8(2):120-7. PubMed ID: 4020943
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of ceftriaxone following intravenous administration of a 3 g dose.
    McNamara PJ, Stoeckel K, Ziegler WH.
    Eur J Clin Pharmacol; 1982 Jun; 22(1):71-5. PubMed ID: 6284519
    [Abstract] [Full Text] [Related]

  • 6. Single-dose pharmacokinetics of ceftriaxone in healthy Chinese adults.
    Zhou HH, Chan YP, Arnold K, Sun M.
    Antimicrob Agents Chemother; 1985 Feb; 27(2):192-6. PubMed ID: 3985603
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of cefotiam administered intravenously and intramuscularly to healthy adults.
    Brisson AM, Bryskier A, Millerioux L, Fourtillan JB.
    Antimicrob Agents Chemother; 1984 Oct; 26(4):513-8. PubMed ID: 6097166
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics and tolerance of ceftriaxone in humans after single-dose intramuscular administration in water and lidocaine diluents.
    Patel IH, Weinfeld RE, Konikoff J, Parsonnet M.
    Antimicrob Agents Chemother; 1982 Jun; 21(6):957-62. PubMed ID: 6287931
    [Abstract] [Full Text] [Related]

  • 9. Age and ceftriaxone kinetics.
    Luderer JR, Patel IH, Durkin J, Schneck DW.
    Clin Pharmacol Ther; 1984 Jan; 35(1):19-25. PubMed ID: 6317271
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetic profile of ceftriaxone in man.
    Patel IH, Kaplan SA.
    Am J Med; 1984 Oct 19; 77(4C):17-25. PubMed ID: 6093513
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of cefodizime following single doses of 0.5, 1.0, 2.0, and 3.0 grams administered intravenously to healthy volunteers.
    Lenfant B, Namour F, Logeais C, Coussediere D, Rivault O, Bryskier A, Surjus A.
    Antimicrob Agents Chemother; 1995 Sep 19; 39(9):2037-41. PubMed ID: 8540712
    [Abstract] [Full Text] [Related]

  • 12. Single-dose ceftriaxone kinetics in the newborn.
    Schaad UB, Hayton WL, Stoeckel K.
    Clin Pharmacol Ther; 1985 May 19; 37(5):522-8. PubMed ID: 3987175
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of ceftriaxone in patients with renal failure and in those undergoing hemodialysis.
    Cohen D, Appel GB, Scully B, Neu HC.
    Antimicrob Agents Chemother; 1983 Oct 19; 24(4):529-32. PubMed ID: 6316845
    [Abstract] [Full Text] [Related]

  • 14. Single-dose pharmacokinetics of ceftriaxone in infants and young children.
    Schaad UB, Stoeckel K.
    Antimicrob Agents Chemother; 1982 Feb 19; 21(2):248-53. PubMed ID: 6280597
    [Abstract] [Full Text] [Related]

  • 15. The human pharmacokinetics of cefotaxime and its metabolites and the role of renal tubular secretion on their elimination.
    Ings RM, Reeves DS, White LO, Bax RP, Bywater MJ, Holt HA.
    J Pharmacokinet Biopharm; 1985 Apr 19; 13(2):121-42. PubMed ID: 4057054
    [Abstract] [Full Text] [Related]

  • 16. Comparative pharmacokinetics of ceftriaxone after subcutaneous and intravenous administration.
    Borner K, Lode H, Hampel B, Pfeuffer M, Koeppe P.
    Chemotherapy; 1985 Apr 19; 31(4):237-45. PubMed ID: 4028870
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of ceftriaxone and its relation to concentrations in extravascular compartments. Comparison with cefotaxime.
    Regamey C.
    Chemotherapy; 1985 Apr 19; 31(2):85-94. PubMed ID: 3987394
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of ceftriaxone in pediatric patients with meningitis.
    Steele RW, Eyre LB, Bradsher RW, Weinfeld RE, Patel IH, Spicehandler J.
    Antimicrob Agents Chemother; 1983 Feb 19; 23(2):191-4. PubMed ID: 6301362
    [Abstract] [Full Text] [Related]

  • 19. Difference in blister fluid penetration after single and multiple doses of ceftriaxone.
    LeBel M, Grégoire S, Caron M, Bergeron MG.
    Antimicrob Agents Chemother; 1985 Jul 19; 28(1):123-7. PubMed ID: 4037771
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of ceftriaxone in patients with renal and liver insufficiency and correlations with a physiologic nonlinear protein binding model.
    Stoeckel K, Koup JR.
    Am J Med; 1984 Oct 19; 77(4C):26-32. PubMed ID: 6093514
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.